申请人:——
公开号:US20020032218A1
公开(公告)日:2002-03-14
Compounds of formula I activate the insulin receptor kinase. Pharmaceutical compositions comprising the compounds, and methods of treatment of hyperglycemia and other diseases involving imbalance of glucose levels, especially for the treatment of type II diabetes, by administering these compounds to mannnalian hosts, and processes for their preparation, are also described.
式I的化合物能激活胰岛素受体激酶。包括这些化合物的药物组合物,以及治疗高血糖和其他涉及葡萄糖水平失衡的疾病的方法,特别是治疗2型糖尿病的方法,通过向哺乳动物宿主投药这些化合物,并描述了它们的制备过程。